Your browser doesn't support javascript.
loading
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.
Desta, Zeruesenay; Gammal, Roseann S; Gong, Li; Whirl-Carrillo, Michelle; Gaur, Aditya H; Sukasem, Chonlaphat; Hockings, Jennifer; Myers, Alan; Swart, Marelize; Tyndale, Rachel F; Masimirembwa, Collen; Iwuchukwu, Otito F; Chirwa, Sanika; Lennox, Jeffrey; Gaedigk, Andrea; Klein, Teri E; Haas, David W.
Afiliación
  • Desta Z; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Gammal RS; Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences University School of Pharmacy, Boston, Massachusetts, USA.
  • Gong L; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Gaur AH; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Sukasem C; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Hockings J; Division of Pharmacogenomics and Personalized Medicine, Faculty of Medicine Ramathibodi Hospital, Department of Pathology, Mahidol University, Bangkok, Thailand.
  • Myers A; Laboratory for Pharmacogenomics, Faculty of Medicine Ramathibodi Hospital, Somdech Phra Debaratana Medical Center, Bangkok, Thailand.
  • Swart M; Department of Pharmacy and Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Tyndale RF; Department of Diagnostic & Biomedical Sciences, The University of Texas Health Sciences Center School of Dentistry, Houston, Texas, USA.
  • Masimirembwa C; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Iwuchukwu OF; Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
  • Chirwa S; African Institute of Biomedical Science & Technology, Wilkins Hospital, Harare, Zimbabwe.
  • Lennox J; Division of Pharmaceutical Sciences, Fairleigh Dickinson University School of Pharmacy, Florham Park, New Jersey, USA.
  • Gaedigk A; Department of Internal Medicine, Meharry Medical College School of Medicine, Nashville, Tennessee, USA.
  • Klein TE; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Haas DW; Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.
Clin Pharmacol Ther ; 106(4): 726-733, 2019 10.
Article en En | MEDLINE | ID: mdl-31006110
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Benzoxazinas / Citocromo P-450 CYP2B6 / Pruebas de Farmacogenómica Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Benzoxazinas / Citocromo P-450 CYP2B6 / Pruebas de Farmacogenómica Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos